Certification Rate
100%
Very high DOL cert
A DOL Labor Condition Application record spanning FY2023–2026. Review the filing volume, DOL certification record, and offered-wage context below.
Central Islip, NY NAICS: 325412
U.S. Department of Labor's OFLC discloses 53 Labor Condition Application filings naming Ascent Pharmaceuticals, INC. from FY2023 through FY2026, drawn directly from DOL's quarterly public disclosure releases. An LCA is the wage-and-working-conditions attestation an employer files with DOL before petitioning USCIS for an H-1B worker: it is a filing record, not a USCIS approval, a job offer, or a confirmed hire, and the count reflects filings, not people, since an employer sponsoring the same role at more than one worksite, or refiling across fiscal years, is counted once per filing. See filing history · Recent LCAs
Separate from the DOL filing record above, U.S. Citizenship and Immigration Services adjudicated 165 H-1B petitions naming Ascent Pharmaceuticals, INC. through FY2024, and approved nearly every one of them: 99.4% approved (164 approvals, 1 denials). A DOL certification is the labor-condition step filed before a petition; this USCIS figure is the actual adjudicated outcome, and the two rates commonly differ.
The verdict
Ascent Pharmaceuticals, INC. is listed in 53 DOL LCA filings, more filings than 96% of employer filers in this extract. DOL certified 100% of those LCAs; the median listed offered wage is $90,014. This is not a USCIS approval, hiring, or sponsorship ranking.
According to U.S. Department of Labor OFLC LCA disclosure files (FY2023–FY2026). Based in Central Islip, NY.
Ascent Pharmaceuticals, INC. vs all U.S. employer filers by LCA volume
Where this employer's disclosed Labor Condition Application count sits among every tracked employer filer (inventory signal, not a sponsorship ranking)
53 4955th of 122824 higher than 117,869 of 122,824 employer filers
Employer filers, banded by disclosed H-1B LCA filing count
Each bar is a band; taller bars hold more employer filers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source U.S. Department of Labor OFLC · FY2023–FY2026
Derived from this employer's disclosed LCAs on file (FY2023–FY2026), title mix and worksite counties, not national boilerplate. LCA filings do not establish USCIS outcomes or confirmed hiring.
Offered-wage span on file: $62,000–$225,670 .
DOL LCA release change
On 53 LCAs with comparable offered vs prevailing wages, Ascent Pharmaceuticals, INC. averages about 15.3% above the prevailing wage (national baseline ≈ 17.8%). Dominant PW level on file: Entry (Level I) (52.8% of LCA filings).
Completed-year LCA counts rose from 10 in FY2023 to 26 in FY2025 (≈2.6×). Cumulative volume: 53.
Only 53 LCAs on file for Ascent Pharmaceuticals, INC., and 88.7% land in SUFFOLK, NY. Treat rates as descriptive of a small sample. DOL cert on file: 100%.
Certification Rate
100%
Very high DOL cert
Avg. Salary
$90,014
Below portal avg
Total Workers
53
Moderate worker count
Compensation range for H-1B positions at Ascent Pharmaceuticals, INC.
Wage vs. DOL Minimum
+15.3%
Above DOL floor
national avg +17.8%
Typical DOL Wage Level
Entry (Level I)
52.8% of LCA filings
Full-Time Positions
100%
Primary Worksite County
SUFFOLK, NY
88.7% of LCA filings
Most frequently listed job titles at Ascent Pharmaceuticals, INC.
| Job Title | LCA filings | Avg. Salary |
|---|---|---|
| Quality Control Chemist | 15 | $82,502 |
| Analytical Chemist | 12 | $71,058 |
| Quality Assurance Chemist | 5 | $70,595 |
| Sr. Quality Assurance Scientist | 3 | $209,003 |
| Manufacturing Chemist | 3 | $72,000 |
| Formulation Chemist | 3 | $67,867 |
| Regulatory Affairs Specialist | 2 | $86,000 |
| Supply Chain Specialist | 1 | $63,000 |
| Sr. Regulatory Affairs Specialist | 1 | $110,500 |
| Sr. Formulation Chemist | 1 | $100,000 |
| Sr. Analytical Chemist | 1 | $108,000 |
| Senior Regulatory Affairs Specialist | 1 | $120,000 |
| Quality Control Scientist | 1 | $119,800 |
| QA Scientist | 1 | $155,000 |
| QA Engineer | 1 | $116,000 |
Cross-state DOL neighbors for Ascent Pharmaceuticals, INC. - LCA filing-count and offered-wage axes, outside NY.
Nearest cross-state employer filers by LCA filing count (53 here; floor ≥10 LCA filings).
Cross-state employer filers with a comparable average listed offered wage ($90,014 here).
Ascent Pharmaceuticals, INC. is listed in 53 DOL Labor Condition Application filings covering 53 listed worker positions from FY2023 to FY2026. An LCA is a Labor Department filing record, not confirmation of a USCIS petition, hire, sponsorship, or visa approval.
Among 122,824 employer filers in the DOL disclosure extract, Ascent Pharmaceuticals, INC. ranks #4867 by total LCA filing count (53 filings). 117,869 employer filers have fewer disclosed filings in this extract. This is a filing-volume comparison only, not a USCIS approval, hiring, or sponsorship ranking.
Ascent Pharmaceuticals, INC. has a 100% DOL certification rate, with 53 out of 53 LCA filings certified. That is the Labor Department step, not a USCIS visa approval rate.
The average offered wage listed in Ascent Pharmaceuticals, INC.'s LCAs is $90,014. Listed wages range from $62,000 to $225,670 and are not verified actual compensation.
The top job titles in Ascent Pharmaceuticals, INC.'s LCA filing records include Quality Control Chemist, Analytical Chemist, Quality Assurance Chemist. The most common listed title is Quality Control Chemist with 15 LCA filings at an average listed offered wage of $82,502. This does not establish actual job openings, hiring, or approved petitions.
Ascent Pharmaceuticals, INC. is headquartered in Central Islip, NY.
No, Ascent Pharmaceuticals, INC. is not classified as H-1B dependent.
Ascent Pharmaceuticals, INC. is listed in 10 LCA filings in FY2023 and 4 in FY2026. The average listed offered wage increased from $103,425 to $158,298. This historical filing series does not predict sponsorship, hiring, or visa outcomes.
Disclaimer: Informational only, not professional advice.
ABS(total_petitions) peers first, then a LARGEST-distance pole and a stamp-branched drill, not a fixed Related strip. This page stamps MICRO-BOOK · CERT-LOCK · WAGE-BELOW.
ABS(total_petitions) peer at 53 LCAs (Δ 0 heavier vs Ascent Pharmaceuticals, INC.); CERT-LOCK · WAGE-ELITE vs this page's MICRO-BOOK · CERT-LOCK · WAGE-BELOW.
ABS(total_petitions) peer at 53 LCAs (Δ 0 heavier vs Ascent Pharmaceuticals, INC.); CERT-CLEAN · WAGE-BELOW vs this page's MICRO-BOOK · CERT-LOCK · WAGE-BELOW.
ABS(total_petitions) peer at 53 LCAs (Δ 0 heavier vs Ascent Pharmaceuticals, INC.); CERT-LOCK · WAGE-BELOW vs this page's MICRO-BOOK · CERT-LOCK · WAGE-BELOW.
ABS(total_petitions) peer at 53 LCAs (Δ 0 heavier vs Ascent Pharmaceuticals, INC.); CERT-SOLID · WAGE-BELOW vs this page's MICRO-BOOK · CERT-LOCK · WAGE-BELOW.
NY pole at 6,144 LCAs stamps HEAVY-BOOK · CERT-LOCK, farthest ABS(total_petitions) contrast from Ascent Pharmaceuticals, INC.'s MICRO-BOOK.
Open the NY state board after the ABS peers. Ascent Pharmaceuticals, INC. stamps MICRO-BOOK · CERT-LOCK inside that worksite mix.
Ascent Pharmaceuticals, INC.'s WAGE-BELOW · MICRO-BOOK stamps sit mid-band. Wage levels I-IV explain the floor behind the offer.
What to do with this profile
Use the DOL LCA record for Ascent Pharmaceuticals, INC. to compare filing volume and offered wages, not USCIS outcomes.
DOL disclosure data only. Not legal advice, sponsorship guarantees, or visa eligibility.
Every figure on PlainVisa is rendered directly from federal source data, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error. Data current as of 2026-09-09.